Vera Therapeutics Inc - Ordinary Shares - Class A

NASDAQ:VERA   10:27:37 AM EDT
16.76
-0.67 (-3.84%)
Earnings Announcements

Vera Therapeutics Reports Second Quarter 2021 Financial Results

Published: 08/16/2021 12:01 GMT
Vera Therapeutics Inc - Ordinary Shares - Class A (VERA) - Vera Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update.
Vera Therapeutics Inc - Qtrly Loss per Share $0.33.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.60

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.83

More details on our Analysts Page.